BRPI0405939A - Formulações antibacterianas de uso tópico - Google Patents

Formulações antibacterianas de uso tópico

Info

Publication number
BRPI0405939A
BRPI0405939A BR0405939-5A BRPI0405939A BRPI0405939A BR PI0405939 A BRPI0405939 A BR PI0405939A BR PI0405939 A BRPI0405939 A BR PI0405939A BR PI0405939 A BRPI0405939 A BR PI0405939A
Authority
BR
Brazil
Prior art keywords
methods
antibacterial formulations
topical use
topical
formulations
Prior art date
Application number
BR0405939-5A
Other languages
English (en)
Inventor
Karl F Popp
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Publication of BRPI0405939A publication Critical patent/BRPI0405939A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
    • A47J36/00—Parts, details or accessories of cooking-vessels
    • A47J36/06—Lids or covers for cooking-vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMULAçõES ANTIBACTERIANAS DE USO TóPICO". A presente invenção refere-se a métodos de uso de uma composição tópica compreendendo uma mistura estável ao armazenamento de uma dispersão de peróxido de benzoíla e clindamicina ou sais ou ésteres farmaceuticamente aceitáveis da mesma para tratar um distúrbio bacteriano. Estes métodos também contemplam a redução ou eliminação de bactérias específicas de áreas afetadas da pele, dessa forma reduzindo lesões ou infecções de pele.
BR0405939-5A 2004-02-27 2004-12-22 Formulações antibacterianas de uso tópico BRPI0405939A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/787,231 US20040167223A1 (en) 2002-09-03 2004-02-27 Topical antibacterial formulations

Publications (1)

Publication Number Publication Date
BRPI0405939A true BRPI0405939A (pt) 2005-11-08

Family

ID=34750504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0405939-5A BRPI0405939A (pt) 2004-02-27 2004-12-22 Formulações antibacterianas de uso tópico

Country Status (6)

Country Link
US (1) US20040167223A1 (pt)
EP (1) EP1568370A1 (pt)
JP (1) JP2005239705A (pt)
KR (1) KR20050087732A (pt)
BR (1) BRPI0405939A (pt)
CA (1) CA2491203A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US7670608B2 (en) * 2003-03-06 2010-03-02 Botulinum Toxin Research Associates, Inc. Selection of patients with increased responsiveness to botulinum toxin
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050095245A1 (en) * 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
JP2005289953A (ja) * 2004-03-31 2005-10-20 Kobayashi Pharmaceut Co Ltd パラオキシ安息香酸メチルを有効成分とする抗菌剤及びこれを含有する外用組成物
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
WO2006055869A2 (en) * 2004-11-19 2006-05-26 Aventis Pharmaceuticals Inc. Antibiotic compounds, compositions and medical uses
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
BRPI0620907A2 (pt) * 2006-01-05 2011-11-29 Drugtech Corp composição farmacêutica, sistema de distribuição de droga vaginal e uso da composição farmacêutica
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
US20070179810A1 (en) * 2006-01-05 2007-08-02 Goodman Edward L Controls for antimicrobial use and infection
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
AU2011244882C1 (en) * 2006-03-31 2012-07-19 Stiefel Research Australia Pty Ltd Foamable Suspension Gel
EP2010133B1 (en) 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
US20080026039A1 (en) * 2006-07-26 2008-01-31 Stiefel Laboratories, Inc. Benzoyl peroxide pads and formulations therefor
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
AU2008261901A1 (en) * 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
US8741325B2 (en) * 2008-12-18 2014-06-03 The Hong Kong University Of Science And Technology Material for forming a multi-level antimicrobial surface coating and its preparation
WO2011101868A2 (en) 2010-02-18 2011-08-25 Helios Pharmaceuticals Private Limited Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
FR2991872B1 (fr) * 2012-06-15 2014-06-06 Oreal Composition cosmetique comprenant un derive acide imido-peroxycarboxylique et un compose mono-alkyl sulfosuccinate
PL3324938T3 (pl) * 2015-07-20 2022-01-10 Trilogic Pharma Llc Preparaty do stosowania miejscowego i sposoby leczenia
RU2019134342A (ru) * 2017-03-30 2021-04-28 Сайнтелл, Ллк Способ лечения и предупреждения инфекций
CN109529065A (zh) * 2018-12-27 2019-03-29 湖北远大天天明制药有限公司 一种卡波姆分散灭菌方法及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952099A (en) * 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4075353A (en) * 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4443442A (en) * 1979-12-21 1984-04-17 Skillern Scott D Method and composition for treatment of acne vulgaris
US4692329A (en) * 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
LU85111A1 (fr) * 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
US4731362A (en) * 1985-08-05 1988-03-15 Shionogi & Co., Ltd. Alkylcarbamoyloxymethylcephem compounds
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
FR2604435B1 (fr) * 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
FR2604357B1 (fr) * 1986-09-30 1988-12-02 Oreal Composition pharmaceutique et cosmetique anti-acneique
SK43294A3 (en) * 1991-10-16 1995-01-12 Richardson Vicks Inc Agent improving the penetration of treatments at surface application
BR9206630A (pt) * 1991-10-16 1995-04-25 Richardson Vicks Inc Gel cosmético aquoso de baixo pH contendo derivados não iônicos de poliacrilamida
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5948416A (en) * 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
US6221847B1 (en) * 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
FR2754176B1 (fr) * 1996-10-07 1999-12-10 Roche Posay Lab Pharma Emulsion e/h a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US6150381A (en) * 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
BRPI0406905B8 (pt) * 2003-01-24 2021-05-25 Connetics Australia Pty Ltd composição de distribuição tópica em um recipiente pressurizado
US20040156873A1 (en) * 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions

Also Published As

Publication number Publication date
US20040167223A1 (en) 2004-08-26
EP1568370A1 (en) 2005-08-31
KR20050087732A (ko) 2005-08-31
JP2005239705A (ja) 2005-09-08
CA2491203A1 (en) 2005-08-27

Similar Documents

Publication Publication Date Title
BRPI0405939A (pt) Formulações antibacterianas de uso tópico
WO2007092312A3 (en) Topical skin treating compositions
BR112013005426A2 (pt) "composto, composição, formulação farmacêutica, métodos para inibir uma enzima, para matar e/ou prevenir o crescimento de um micro-organismo, para tratar e/ou prevenir uma doença em um animal, e para inibir o domínio de edição de uma sintetase de t-rna, e, uso de um composto ou uma de combinação."
WO2007002831A3 (en) Topical skin treating compostions
BRPI0405732A (pt) Formulações tópicas para tratamento de rosácea
AU2001271545A1 (en) Promoting whole body health
WO2010108187A3 (en) Compounds and methods for treating mammalian gastrointestinal microbial infections
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
NZ718955A (en) Compositions comprising povidone-iodine
BR112012002578B8 (pt) usos de treprostinil ou de um derivado ou de um sal farmaceuticamente aceitável do mesmo para tratamento da fibrose cística
BR0012674A (pt) Formulações farmacêuticas preservadas
NZ631469A (en) Aerosol fluoroquinolone formulations for improved pharmacokinetics
BRPI0517481A (pt) método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
BRPI0510110A (pt) método para tratar, prevenir ou controlar hipertensão pulmonar, e, composição farmacêutica
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
BRPI0916885B8 (pt) composição farmacêutica
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
BR112021018815A2 (pt) Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário
WO2005099655A2 (en) Antimicrobial cleansing compositions and methods of use
MX2023011616A (es) Compuestos de lactivicina, su preparacion y uso como agentes antibacterianos.
BR112012020377A8 (pt) utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial
WO2007071965A3 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
WO2007124382A3 (en) Inhaled imipenem

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.